vs
Side-by-side financial comparison of Five9, Inc. (FIVN) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $300.3M, roughly 1.3× Five9, Inc.). On growth, Five9, Inc. posted the faster year-over-year revenue change (7.8% vs 3.8%). Over the past eight quarters, Five9, Inc.'s revenue compounded faster (10.3% CAGR vs -0.5%).
Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
FIVN vs PIII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $300.3M | $384.8M |
| Net Profit | — | $-75.5M |
| Gross Margin | 55.4% | — |
| Operating Margin | 6.6% | -40.0% |
| Net Margin | — | -19.6% |
| Revenue YoY | 7.8% | 3.8% |
| Net Profit YoY | — | -28.8% |
| EPS (diluted) | $0.22 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $300.3M | $384.8M | ||
| Q3 25 | $285.8M | $345.3M | ||
| Q2 25 | $283.3M | $355.8M | ||
| Q1 25 | $279.7M | $373.2M | ||
| Q4 24 | $278.7M | $370.7M | ||
| Q3 24 | $264.2M | $362.1M | ||
| Q2 24 | $252.1M | $379.2M | ||
| Q1 24 | $247.0M | $388.5M |
| Q4 25 | — | $-75.5M | ||
| Q3 25 | $18.0M | $-31.6M | ||
| Q2 25 | $1.2M | $-20.4M | ||
| Q1 25 | $576.0K | $-20.5M | ||
| Q4 24 | — | $-58.6M | ||
| Q3 24 | $-4.5M | $-46.5M | ||
| Q2 24 | $-12.8M | $-12.0M | ||
| Q1 24 | $-7.1M | $-18.7M |
| Q4 25 | 55.4% | — | ||
| Q3 25 | 55.0% | — | ||
| Q2 25 | 54.9% | — | ||
| Q1 25 | 55.0% | — | ||
| Q4 24 | 56.0% | — | ||
| Q3 24 | 53.8% | — | ||
| Q2 24 | 53.0% | — | ||
| Q1 24 | 53.6% | — |
| Q4 25 | 6.6% | -40.0% | ||
| Q3 25 | 5.6% | -12.8% | ||
| Q2 25 | -0.6% | -9.6% | ||
| Q1 25 | -1.9% | -10.2% | ||
| Q4 24 | 1.5% | -37.4% | ||
| Q3 24 | -5.8% | -29.5% | ||
| Q2 24 | -7.7% | -8.3% | ||
| Q1 24 | -8.4% | -11.3% |
| Q4 25 | — | -19.6% | ||
| Q3 25 | 6.3% | -9.1% | ||
| Q2 25 | 0.4% | -5.7% | ||
| Q1 25 | 0.2% | -5.5% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | -1.7% | -12.8% | ||
| Q2 24 | -5.1% | -3.2% | ||
| Q1 24 | -2.9% | -4.8% |
| Q4 25 | $0.22 | $-23.08 | ||
| Q3 25 | $0.21 | $-9.67 | ||
| Q2 25 | $0.01 | $-6.23 | ||
| Q1 25 | $0.01 | $-6.28 | ||
| Q4 24 | $0.16 | $-23.13 | ||
| Q3 24 | $-0.06 | $-15.70 | ||
| Q2 24 | $-0.17 | $-7.37 | ||
| Q1 24 | $-0.10 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $232.1M | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | $785.8M | $-155.2M |
| Total Assets | $1.8B | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $232.1M | $25.0M | ||
| Q3 25 | $193.4M | $37.7M | ||
| Q2 25 | $205.5M | $38.6M | ||
| Q1 25 | $370.3M | $40.1M | ||
| Q4 24 | $362.5M | $38.8M | ||
| Q3 24 | $291.0M | $63.0M | ||
| Q2 24 | $175.7M | $73.1M | ||
| Q1 24 | $240.2M | $27.3M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
| Q4 25 | $785.8M | $-155.2M | ||
| Q3 25 | $775.3M | $-18.7M | ||
| Q2 25 | $717.4M | $44.5M | ||
| Q1 25 | $664.3M | $63.3M | ||
| Q4 24 | $622.2M | $75.9M | ||
| Q3 24 | $565.6M | $120.5M | ||
| Q2 24 | $525.9M | $166.8M | ||
| Q1 24 | $483.6M | $146.6M |
| Q4 25 | $1.8B | $656.6M | ||
| Q3 25 | $1.8B | $683.6M | ||
| Q2 25 | $1.7B | $731.6M | ||
| Q1 25 | $2.1B | $783.9M | ||
| Q4 24 | $2.1B | $783.4M | ||
| Q3 24 | $2.0B | $833.3M | ||
| Q2 24 | $1.9B | $892.8M | ||
| Q1 24 | $1.9B | $855.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $83.6M | $-25.7M |
| Free Cash FlowOCF − Capex | $77.3M | — |
| FCF MarginFCF / Revenue | 25.8% | — |
| Capex IntensityCapex / Revenue | 2.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $201.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.6M | $-25.7M | ||
| Q3 25 | $59.2M | $-15.4M | ||
| Q2 25 | $35.1M | $-16.6M | ||
| Q1 25 | $48.4M | $-33.5M | ||
| Q4 24 | $49.8M | $-57.2M | ||
| Q3 24 | $41.1M | $-22.6M | ||
| Q2 24 | $19.9M | $-10.2M | ||
| Q1 24 | $32.4M | $-20.0M |
| Q4 25 | $77.3M | — | ||
| Q3 25 | $48.7M | — | ||
| Q2 25 | $31.6M | — | ||
| Q1 25 | $43.7M | — | ||
| Q4 24 | $40.5M | — | ||
| Q3 24 | $26.7M | — | ||
| Q2 24 | $13.1M | — | ||
| Q1 24 | $20.4M | — |
| Q4 25 | 25.8% | — | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 15.6% | — | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 10.1% | — | ||
| Q2 24 | 5.2% | — | ||
| Q1 24 | 8.3% | — |
| Q4 25 | 2.1% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 3.3% | 0.0% | ||
| Q3 24 | 5.4% | 0.0% | ||
| Q2 24 | 2.7% | 0.0% | ||
| Q1 24 | 4.8% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 3.29× | — | ||
| Q2 25 | 30.38× | — | ||
| Q1 25 | 84.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FIVN
Segment breakdown not available.
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
